Antibiotic combinations for severe pneumonia
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study looks at whether giving two antibiotics together is better for people hospitalized with severe pneumonia. It may help doctors choose the most effective treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 or older
- You went to the emergency department and were admitted to the hospital
- You have pneumonia confirmed by chest X-ray or CT scan
- You have at least two signs of infection (fever, abnormal white blood cell count, or purulent sputum)
- Within 24 hours of admission, you have severe pneumonia (need a breathing tube, low blood pressure, or certain other serious signs)
- You do not have certain infections like flu or COVID-19, and you have not recently been in the hospital for a long time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how different types of sepsis affect treatment with the antibiotic piperacillin/tazobactam in patients with severe pneumonia. Researchers hope to find better ways to treat each person based on their specific condition.
This trial tests a way to give antibiotics directly to the lungs (inhaled or nebulized) for people hospitalized with moderate to severe pneumonia. The goal is to see if this local treatment works better than standard antibiotics alone and helps you recover faster.
This trial compares how long antibiotics should be given to people hospitalized with moderately severe community-acquired pneumonia. It uses your early improvement to see which antibiotic duration works best and safely.
This study tests different antibiotic combinations for severe infections caused by hard-to-treat Gram-negative bacteria (like Pseudomonas or Acinetobacter). The goal is to find the best treatment for bloodstream infections or pneumonia that started in the hospital.
This study watches how safely two common antibiotics (vancomycin and a combination called piperacillin/tazobactam) work together in hospitalized patients with serious infections. Researchers want to make sure the combination doesn't harm kidney function.
This trial compares two common antibiotics, meropenem and piperacillin/tazobactam, to see which works better for adults with sepsis who are critically ill. It aims to help doctors choose the best treatment for serious infections.
Hear when a new Severe Community-acquired Pneumonia (sCAP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.